Table of Content

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary
2.1 Key Insights

3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Antibiotics and Antimycotics Market Landscape
4.1 Overview
4.2 PEST Analysis

5. Antibiotics and Antimycotics Market – Key Market Dynamics
5.1 Antibiotics and Antimycotics Market – Key Market Dynamics
5.2 Market Drivers:
5.2.1 Increasing Prevalence of Infectious Diseases
5.2.2 Growing Awareness About Fungal Infections
5.3 Market Restraints
5.3.1 Antimicrobial Resistance, Financial Barriers, and Extensive Regulatory Processes
5.4 Market Opportunities
5.4.1 Ongoing Funding and Research & Development Initiatives
5.5 Future Trends
5.5.1 Technological Advancements in Product Development and Treatment Delivery Approaches
5.6 Impact of Drivers and Restraints:

6. Antibiotics and Antimycotics Market – Global Market Analysis
6.1 Antibiotics and Antimycotics Market Revenue (US$ Million), 2021–2031
6.2 Antibiotics and Antimycotics Market Forecast Analysis

7. Antibiotics and Antimycotics Market Analysis – by Drug Class
7.1 Penicillin
7.1.1 Overview
7.1.2 Penicillin: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Cephalosporines
7.2.1 Overview
7.2.2 Cephalosporines: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Carbapenems
7.3.1 Overview
7.3.2 Carbapenems: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Macrolides
7.4.1 Overview
7.4.2 Macrolides: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Aminoglycosides
7.5.1 Overview
7.5.2 Aminoglycosides: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Quinolones
7.6.1 Overview
7.6.2 Quinolones: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Sulfonamides
7.7.1 Overview
7.7.2 Sulfonamides: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Tetracyclines
7.8.1 Overview
7.8.2 Tetracyclines: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Azoles
7.9.1 Overview
7.9.2 Azoles: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

8. Antibiotics and Antimycotics Market Analysis – by Indication
8.1 Skin Infections
8.1.1 Overview
8.1.2 Skin Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Respiratory Infections
8.2.1 Overview
8.2.2 Respiratory Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Urinary Tract Infections (UTI)
8.3.1 Overview
8.3.2 Urinary Tract Infections (UTI): Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Septicemia
8.4.1 Overview
8.4.2 Septicemia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Ear Infections
8.5.1 Overview
8.5.2 Ear Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Gastrointestinal Infections
8.6.1 Overview
8.6.2 Gastrointestinal Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

9. Antibiotics and Antimycotics Market Analysis – by Route Of Administration
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Topical
9.2.1 Overview
9.2.2 Topical: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

10. Antibiotics and Antimycotics Market Analysis – by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Online Pharmacies: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11. Antibiotics and Antimycotics Market – Geographical Analysis
11.1 North America
11.1.1 North America Antibiotics and Antimycotics Market Overview
11.1.2 North America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.1.2.1 North America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Drug Class
11.1.2.2 North America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Indication
11.1.2.3 North America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Route Of Administration
11.1.2.4 North America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Distribution Channel
11.1.3 North America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Country
11.1.3.1 United States: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.1.3.1.1 United States: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.1.3.1.2 United States: Antibiotics and Antimycotics Market Breakdown, by Indication
11.1.3.1.3 United States: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.1.3.1.4 United States: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.1.3.2 Canada: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.1.3.2.1 Canada: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.1.3.2.2 Canada: Antibiotics and Antimycotics Market Breakdown, by Indication
11.1.3.2.3 Canada: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.1.3.2.4 Canada: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.1.3.3 Mexico: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.1.3.3.1 Mexico: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.1.3.3.2 Mexico: Antibiotics and Antimycotics Market Breakdown, by Indication
11.1.3.3.3 Mexico: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.1.3.3.4 Mexico: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.2 Europe
11.2.1 Europe Antibiotics and Antimycotics Market Overview
11.2.2 Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.2.1 Europe: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Drug Class
11.2.2.2 Europe: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Indication
11.2.2.3 Europe: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Route Of Administration
11.2.2.4 Europe: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.3 Europe: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Country
11.2.3.1 Germany: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.1.1 Germany: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.2.3.1.2 Germany: Antibiotics and Antimycotics Market Breakdown, by Indication
11.2.3.1.3 Germany: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.2.3.1.4 Germany: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.2.3.2 France: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.2.1 France: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.2.3.2.2 France: Antibiotics and Antimycotics Market Breakdown, by Indication
11.2.3.2.3 France: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.2.3.2.4 France: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.2.3.3 Spain: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.3.1 Spain: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.2.3.3.2 Spain: Antibiotics and Antimycotics Market Breakdown, by Indication
11.2.3.3.3 Spain: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.2.3.3.4 Spain: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.2.3.4 Italy: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.4.1 Italy: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.2.3.4.2 Italy: Antibiotics and Antimycotics Market Breakdown, by Indication
11.2.3.4.3 Italy: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.2.3.4.4 Italy: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.2.3.5 United Kingdom: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.5.1 United Kingdom: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.2.3.5.2 United Kingdom: Antibiotics and Antimycotics Market Breakdown, by Indication
11.2.3.5.3 United Kingdom: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.2.3.5.4 United Kingdom: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.2.3.6 Rest of Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.6.1 Rest of Europe: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.2.3.6.2 Rest of Europe: Antibiotics and Antimycotics Market Breakdown, by Indication
11.2.3.6.3 Rest of Europe: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.2.3.6.4 Rest of Europe: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.3 Asia Pacific
11.3.1 Asia Pacific Antibiotics and Antimycotics Market Overview
11.3.2 Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.2.1 Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Drug Class
11.3.2.2 Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Indication
11.3.2.3 Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Route Of Administration
11.3.2.4 Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.3 Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Country
11.3.3.1 China: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 China: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.3.3.1.2 China: Antibiotics and Antimycotics Market Breakdown, by Indication
11.3.3.1.3 China: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.3.3.1.4 China: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.3.3.2 Japan: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Japan: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.3.3.2.2 Japan: Antibiotics and Antimycotics Market Breakdown, by Indication
11.3.3.2.3 Japan: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.3.3.2.4 Japan: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.3.3.3 India: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 India: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.3.3.3.2 India: Antibiotics and Antimycotics Market Breakdown, by Indication
11.3.3.3.3 India: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.3.3.3.4 India: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.3.3.4 Australia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Australia: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.3.3.4.2 Australia: Antibiotics and Antimycotics Market Breakdown, by Indication
11.3.3.4.3 Australia: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.3.3.4.4 Australia: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.3.3.5 South Korea: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 South Korea: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.3.3.5.2 South Korea: Antibiotics and Antimycotics Market Breakdown, by Indication
11.3.3.5.3 South Korea: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.3.3.5.4 South Korea: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.3.3.6 Rest of APAC: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Rest of APAC: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.3.3.6.2 Rest of APAC: Antibiotics and Antimycotics Market Breakdown, by Indication
11.3.3.6.3 Rest of APAC: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.3.3.6.4 Rest of APAC: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.4 Middle East and Africa
11.4.1 Middle East and Africa Antibiotics and Antimycotics Market Overview
11.4.2 Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.4.2.1 Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Drug Class
11.4.2.2 Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Indication
11.4.2.3 Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Route Of Administration
11.4.2.4 Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Saudi Arabia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.1.1 Saudi Arabia: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.4.3.1.2 Saudi Arabia: Antibiotics and Antimycotics Market Breakdown, by Indication
11.4.3.1.3 Saudi Arabia: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.4.3.1.4 Saudi Arabia: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.4.3.2 South Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.2.1 South Africa: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.4.3.2.2 South Africa: Antibiotics and Antimycotics Market Breakdown, by Indication
11.4.3.2.3 South Africa: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.4.3.2.4 South Africa: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.4.3.3 United Arab Emirates: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.3.1 United Arab Emirates: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.4.3.3.2 United Arab Emirates: Antibiotics and Antimycotics Market Breakdown, by Indication
11.4.3.3.3 United Arab Emirates: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.4.3.3.4 United Arab Emirates: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.4.3.4 Rest of Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.4.1 Rest of Middle East and Africa: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.4.3.4.2 Rest of Middle East and Africa: Antibiotics and Antimycotics Market Breakdown, by Indication
11.4.3.4.3 Rest of Middle East and Africa: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.4.3.4.4 Rest of Middle East and Africa: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.5 South and Central America
11.5.1 South and Central America Antibiotics and Antimycotics Market Overview
11.5.2 South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.5.2.1 South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Drug Class
11.5.2.2 South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Indication
11.5.2.3 South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Route Of Administration
11.5.2.4 South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.3 South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast Analysis – by Country
11.5.3.1 Brazil: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.1.1 Brazil: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.5.3.1.2 Brazil: Antibiotics and Antimycotics Market Breakdown, by Indication
11.5.3.1.3 Brazil: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.5.3.1.4 Brazil: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.5.3.2 Argentina: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.2.1 Argentina: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.5.3.2.2 Argentina: Antibiotics and Antimycotics Market Breakdown, by Indication
11.5.3.2.3 Argentina: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.5.3.2.4 Argentina: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel
11.5.3.3 Rest of South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.3.1 Rest of South and Central America: Antibiotics and Antimycotics Market Breakdown, by Drug Class
11.5.3.3.2 Rest of South and Central America: Antibiotics and Antimycotics Market Breakdown, by Indication
11.5.3.3.3 Rest of South and Central America: Antibiotics and Antimycotics Market Breakdown, by Route Of Administration
11.5.3.3.4 Rest of South and Central America: Antibiotics and Antimycotics Market Breakdown, by Distribution Channel

12. Antibiotics and Antimycotics Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in Antibiotics and Antimycotics Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview

13. Company Profiles
13.1 Pfizer Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Novartis AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sanofi SA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Merck & Co Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GSK Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Johnson & Johnson
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Cipla Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bayer AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 AbbVie Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Astellas Pharma Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms



List of Figures

LIST OF FIGURES

Figure 1. Antibiotics and Antimycotics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Antibiotics and Antimycotics Market Revenue (US$ Million), 2021–2031
Figure 5. Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 6. Antibiotics and Antimycotics Market Share (%) – by Drug Class (2023 and 2031)
Figure 7. Penicillin: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cephalosporines: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Carbapenems: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Macrolides: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Aminoglycosides: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Quinolones: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Sulfonamides: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Tetracyclines: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Azoles: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Antibiotics and Antimycotics Market Share (%) – by Indication (2023 and 2031)
Figure 18. Skin Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Respiratory Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Urinary Tract Infections (UTI): Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Septicemia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Ear Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Gastrointestinal Infections: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Others: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Antibiotics and Antimycotics Market Share (%) – by Route Of Administration (2023 and 2031)
Figure 26. Oral: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Topical: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Antibiotics and Antimycotics Market Share (%) – by Distribution Channel (2023 and 2031)
Figure 30. Hospital Pharmacies: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Retail Pharmacies: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Online Pharmacies: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 33. North America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. North America: Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 35. United States: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Canada: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Mexico: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Europe: Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 40. Germany: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. France: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Spain: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Italy: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. United Kingdom: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Asia Pacific: Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 48. China: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Japan: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. India: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Australia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. South Korea: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Rest of APAC: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Middle East and Africa: Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 56. Saudi Arabia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. South Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. United Arab Emirates: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Rest of Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 60. South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 61. South and Central America: Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 62. Brazil: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 63. Argentina: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million)
Figure 64. Rest of South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 65. Growth Strategies in Antibiotics and Antimycotics Market

List of Tables

LIST OF TABLES

Table 1. Antibiotics and Antimycotics Market Segmentation
Table 2. North America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 3. North America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 4. North America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 5. North America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 6. United States: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 7. United States: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 8. United States: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 9. United States: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 10. Canada: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 11. Canada: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 12. Canada: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 13. Canada: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 14. Mexico: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 15. Mexico: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 16. Mexico: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 17. Mexico: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 18. Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 19. Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 20. Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 21. Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 22. Germany: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 23. Germany: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 24. Germany: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 25. Germany: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 26. France: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 27. France: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 28. France: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 29. France: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 30. Spain: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 31. Spain: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 32. Spain: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 33. Spain: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 34. Italy: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 35. Italy: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 36. Italy: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 37. Italy: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 38. United Kingdom: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 39. United Kingdom: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 40. United Kingdom: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 41. United Kingdom: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 42. Rest of Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 43. Rest of Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 44. Rest of Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 45. Rest of Europe: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 46. Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 47. Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 48. Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 49. Asia Pacific: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 50. China: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 51. China: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 52. China: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 53. China: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 54. Japan: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 55. Japan: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 56. Japan: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 57. Japan: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 58. India: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 59. India: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 60. India: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 61. India: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 62. Australia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 63. Australia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 64. Australia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 65. Australia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 66. South Korea: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 67. South Korea: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 68. South Korea: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 69. South Korea: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 70. Rest of APAC: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 71. Rest of APAC: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 72. Rest of APAC: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 73. Rest of APAC: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 74. Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 75. Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 76. Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 77. Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 78. Saudi Arabia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 79. Saudi Arabia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 80. Saudi Arabia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 81. Saudi Arabia: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 82. South Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 83. South Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 84. South Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 85. South Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 86. United Arab Emirates: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 87. United Arab Emirates: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 88. United Arab Emirates: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 89. United Arab Emirates: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 90. Rest of Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 91. Rest of Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million) – by Indication
Table 92. Rest of Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 93. Rest of Middle East and Africa: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 94. South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 95. South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 96. South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 97. South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 98. Brazil: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 99. Brazil: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 100. Brazil: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 101. Brazil: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 102. Argentina: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 103. Argentina: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Indication
Table 104. Argentina: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 105. Argentina: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 106. Rest of South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 107. Rest of South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031 (US$ Million) – by Indication
Table 108. Rest of South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 109. Rest of South and Central America: Antibiotics and Antimycotics Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 110. Recent Organic Growth Strategies in Antibiotics and Antimycotics Market
Table 111. Recent Inorganic Growth Strategies in the Antibiotics and Antimycotics Market
Table 112. Glossary of Terms, Antibiotics and Antimycotics Market